President Trump just issued an executive order to rebalance the global pharmaceutical market — by tying U.S. drug prices to ...

On top of that, an analyst cut his price target on the Denmark-based pharmaceutical company. Novo Nordisk (NYSE: NVO) stock ...

On November 5, 2024, voters sent a clear message by electing Donald Trump. In the last five months, President Trump has delivered on the many promises he made t ...

AbbVie Inc. (NYSE:ABBV) is one of the 12 best healthcare stocks to buy now. On June 12, the US Food and Drug Administration (FDA) approved the company’s Mavyret treatment label expansion. The approval ...

President Trump just issued an executive order to rebalance the global pharmaceutical market -- by tying U.S. drug prices to the artificially low, government-set prices in other developed nations.

Administration officials have good intentions. They’re trying to shake up the plainly unacceptable status quo, in which ...

The cost of staying alive could become a lot more expensive for millions of Americans because of Trump drug tariffs - Are you ...

Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

Discover why Tonix Pharmaceuticals Holding Corp. stock could rally with FDA approval for Tonmya targeting fibromyalgia. Click ...

Ebony Price, a recent graduate of the Women's Empowerment program, shares her journey from drug addiction to becoming a peer ...